<div id="readability-page-1"><div><p>Health-care companies rose amid deal activity.</p><p>    Biopharmaceutical company AbbVie is in advanced talks to buy cancer-drug biotech Revolution Medicines. </p><p>    Shares of obesity-drug maker Eli Lilly rose, testing all-time highs. </p><p>    Trump administration officials made sweeping changes to U.S. federal dietary guidelines, recommending that people avoid highly processed foods, dramatically increase protein intake and skip added sugar. </p><p>   Write to Rob Curran at rob.curran@dowjones.com </p><p>    (END) Dow Jones Newswires</p><p>01-07-26 1846ET</p></div></div>

艾伯维

礼来

<p>医疗保健公司在交易活动中上涨。生物制药公司艾伯维正在与癌症药物生物技术公司 Revolution Medicines 进行高级谈判。肥胖药物制造商礼来的股票上涨，测试历史最高点。特朗普政府官员对美国联邦饮食指南进行了大幅修改，建议人们避免高度加工的食品，显著增加蛋白质摄入量，并跳过添加糖。请联系 Rob Curran，邮箱为 rob.curran@dowjones.com (完) 道琼斯新闻社 01-07-26 1846ET</p>

由于交易活动，医疗保健板块上涨——医疗保健综述